Participatory development of audio-delivered interventions and written material and assessment of their impact on the perception and knowledge of and attitudes towards leprosy: A cluster randomised trial in Nigeria
Molecular Mechanisms of Immunomodulation Imparted by Mycobacterium indicus pranii (MIP) vaccine against multibacillary leprosy - M2I2MIP
Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum (MaPS in ENL
Erythema Nodosum Leprosum (ENL) is a painful, debilitating complication of leprosy. Patients often require high doses of corticosteroids for prolonged periods. Thalidomide is expensive and not available in most countries. The use of corticosteroids for long periods is associated with adverse effects and mortality. It is a priority to identify alternative agents to treat ENL. Methotrexate (MTX) is a cheap, widely used medication which has been reported to be effective in ENL resistant to steroids and thalidomide.
100 项与 Leprosy Research Initiative 相关的临床结果
0 项与 Leprosy Research Initiative 相关的专利(医药)
100 项与 Leprosy Research Initiative 相关的药物交易
100 项与 Leprosy Research Initiative 相关的转化医学